Equity ETFs Pharma ETF Looks Healthy in a Sick Market After Endo Names New CEO By Max ChenSeptember 23, 2016
Equity ETFs M&A Activity, Passing Drug Trials Help Biotech ETFs Rebound By Max ChenSeptember 12, 2016
Equity ETFs Pfizer Acquires Anacor, Reviving M&A Bets in Biotech Sector, ETFs By Max ChenMay 16, 2016
